Research & Development



  雲瑯是不信什麼君臣父子這一套的,他只相信實力,只可惜,在大漢,劉徹就是力量。   可是要把上林苑種滿莊稼,是一個幾乎不可能的事情,畢竟,橫亙關中大地三百里的上林苑,實在是太大了。经典AV三级在线   自然是讓自己不斷地變強,讓你雲氏不斷地變強,讓別人覺得對付你雲氏後果嚴重,也就沒人對付你了。亚洲成人视频   如果自家閨女能隨著紅袖唱歌,被她耳濡目染一下把難听的歌喉改變一下也很不錯。   劉徹的報復來的比雲瑯預料的要早,傍晚的時候,宦官隋越就來到雲氏,準備收回雲瑯手里的印鑒,官牒。成人免费视频在线观看   “我不喜歡髒孩子!”

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo